1. Home
  2. CHMG vs ZNTL Comparison

CHMG vs ZNTL Comparison

Compare CHMG & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMG
  • ZNTL
  • Stock Information
  • Founded
  • CHMG 1833
  • ZNTL 2014
  • Country
  • CHMG United States
  • ZNTL United States
  • Employees
  • CHMG N/A
  • ZNTL N/A
  • Industry
  • CHMG Major Banks
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMG Finance
  • ZNTL Health Care
  • Exchange
  • CHMG Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • CHMG 222.5M
  • ZNTL 227.0M
  • IPO Year
  • CHMG N/A
  • ZNTL 2020
  • Fundamental
  • Price
  • CHMG $47.03
  • ZNTL $2.25
  • Analyst Decision
  • CHMG Hold
  • ZNTL Buy
  • Analyst Count
  • CHMG 2
  • ZNTL 8
  • Target Price
  • CHMG $58.50
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • CHMG 8.5K
  • ZNTL 1.6M
  • Earning Date
  • CHMG 01-27-2025
  • ZNTL 02-25-2025
  • Dividend Yield
  • CHMG 2.63%
  • ZNTL N/A
  • EPS Growth
  • CHMG N/A
  • ZNTL N/A
  • EPS
  • CHMG 4.53
  • ZNTL N/A
  • Revenue
  • CHMG $93,478,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • CHMG N/A
  • ZNTL N/A
  • Revenue Next Year
  • CHMG $9.26
  • ZNTL N/A
  • P/E Ratio
  • CHMG $10.40
  • ZNTL N/A
  • Revenue Growth
  • CHMG N/A
  • ZNTL N/A
  • 52 Week Low
  • CHMG $39.00
  • ZNTL $2.16
  • 52 Week High
  • CHMG $55.73
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • CHMG 40.98
  • ZNTL 32.94
  • Support Level
  • CHMG $46.44
  • ZNTL $2.16
  • Resistance Level
  • CHMG $47.33
  • ZNTL $2.93
  • Average True Range (ATR)
  • CHMG 0.92
  • ZNTL 0.28
  • MACD
  • CHMG 0.05
  • ZNTL -0.07
  • Stochastic Oscillator
  • CHMG 54.74
  • ZNTL 7.69

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. It provides financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, securities, and insurance brokerage services. Its business operations are organized into two lines of business: Banking, and Wealth Management services. It derives its revenues from the core banking business.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: